US Executive Compensation Proxy SEC Filings — April 21, 2026

21-04-2026

Odyssey Marine Exploration, Inc. (OMEX) issued its 2026 proxy statement for the annual stockholder meeting on June 1, 2026, seeking approval to elect five directors, ratify Grant Thornton LLP as auditors for FY 2026, increase authorized common stock from 75,000,000 to 82,000,000 shares, add 2,000,000 shares to the 2019 Stock Incentive Plan, approve a reverse stock split at a 1-for-20 to 1-for-25 ratio, and conduct an advisory vote on executive compensation. A recent development includes a Merger Agreement announced April 8, 2026, under which a subsidiary will merge with American Ocean Minerals Corporation (AOM), with AOM surviving as a wholly owned subsidiary expected to close in late Q2 to early Q3 2026; merger-related votes will occur at a separate special meeting. No period-over-period financial performance data or compensation figures are detailed in the provided content.

• ·Annual Meeting date and time: 9:30 a.m. EDT on June 1, 2026, at Hampton Inn & Suites, 5329 Avion Park Drive, Tampa, Florida 33607
• ·Reverse stock split ratio range: 1-for-20 to 1-for-25, no change to authorized shares, timing at Board discretion
• ·Merger Form S-4 registration to be filed with SEC; proxy statement/prospectus to follow

21-04-2026

First Guaranty Bancshares, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Shareholders on May 21, 2026, at 2:00 p.m. local time in Hammond, Louisiana, to elect seven directors, approve an advisory non-binding resolution on executive compensation, and ratify EisnerAmper, LLP as the independent registered public accounting firm for the year ending December 31, 2026. The record date is March 30, 2026, with 15,793,433 shares of $1 par value common stock outstanding, each entitled to one vote; preferred stock does not vote. No other financial metrics or period comparisons are provided in the filing.

• ·Meeting quorum requires presence of holders of a majority of outstanding common shares.
• ·Directors elected by plurality vote; advisory vote on executive compensation and auditor ratification each require majority of shares cast.
• ·Proxy materials first mailed on or about April 21, 2026; virtual attendance options provided via website and phone.
• ·Board nominees include Marshall T. Reynolds (age 89, Director since 1993), Jack Rossi (age 81, since 2018), Edgar R. Smith III (age 62, since 2007), and Vanessa R. Drew (age 70, since 2022).

21-04-2026

AppLovin reported exceptional 2025 financial performance with $5.5B revenue (+70% YoY), $4.5B Adjusted EBITDA (+87% YoY), and $4.0B Free Cash Flow (+91% YoY), alongside $2.2B in Class A stock repurchases and a $3.2B increase in repurchase authorization. The company sold its Apps business to focus on the core advertising platform, launching the rebranded Axon Ads Manager and enhancing Axon AI. Governance updates include Craig Billings transitioning to independent Chairperson, with the annual meeting on June 3, 2026, proposing election of nine directors, auditor ratification, say-on-pay, officer exculpation amendment, and a stockholder proposal on voting disclosure.

• ·Annual meeting date: June 3, 2026 at 10:00 a.m. PT, virtual at www.virtualshareholdermeeting.com/APP2026
• ·Record date: April 13, 2026
• ·Alyssa Harvey Dawson not standing for re-election
• ·Board recommendations: FOR director elections, auditor ratification (Deloitte & Touche LLP for FY ending Dec 31, 2026), say-on-pay, officer exculpation amendment; AGAINST stockholder proposal on voting results disclosure by share class
• ·6 of 9 director nominees independent; Independent Chairperson
• ·No executive base salary increases since IPO; No annual cash bonus program for executives

21-04-2026

NCR Voyix Corporation's DEF 14A proxy statement for the June 3, 2026 virtual annual meeting (record date March 16, 2026) proposes electing eight directors (James G. Kelly, Janet Haugen, Irv Henderson, Kirk Larsen, Laura Miller, Kevin Reddy, Laura Sen, Jeffrey Sloan), advisory approval of named executive officer compensation, ratification of PricewaterhouseCoopers LLP as auditors for FY 2026, and approval of the 2026 Stock Incentive Plan to replace the expiring 2017 plan. CEO James G. Kelly's letter highlights 2025 progress in cost alignment post spin-off and divestitures, customer/employee engagement, and software modernization with 20 early adopters of next-generation products across regions; no declines or challenges are mentioned. The document references pay versus performance disclosures and director qualifications but provides no specific financial metrics or period-over-period comparisons.

• ·Annual Meeting: 9:30 a.m. ET, June 3, 2026, virtual via www.virtualshareholdermeeting.com/VYX2026
• ·Record Date: March 16, 2026 for common stock and Series A Convertible Preferred Stock holders voting as single class
• ·2017 Stock Incentive Plan expires May 2027
• ·Fiscal year end for auditor ratification: December 31, 2026

21-04-2026

OUTFRONT Media Inc. filed its DEF 14A proxy statement dated April 21, 2026, for the 2026 Annual Meeting of Stockholders on June 3, 2026, at 10:00 a.m. ET via live audio webcast. Shareholders will vote on electing director nominees to serve until the 2027 meeting, ratifying PricewaterhouseCoopers LLP as independent auditors for fiscal year 2026, approving named executive officer compensation on a non-binding advisory basis, and approving the Amended and Restated Omnibus Stock Incentive Plan. The record date is April 10, 2026, with proxy materials available on or about April 21, 2026.

• ·Annual Meeting location: www.virtualshareholdermeeting.com/OUT2026
• ·Voting methods: internet, telephone, or mail
• ·Proxy materials include 2025 Annual Report on Form 10-K

21-04-2026

PennyMac Mortgage Investment Trust's 2026 Proxy Statement seeks shareholder approval for the election of three Class II trustees (Preston DuFauchard, Nancy McAllister, and Stacey D. Stewart), ratification of the independent registered public accounting firm for the fiscal year ending December 31, 2026, and an advisory vote to approve executive compensation. The document highlights strong corporate governance features, including 78% independent trustees, robust share ownership guidelines (5x base retainer for non-management trustees, $2 million for CEO, $500,000 for other executives), shareholder rights to amend bylaws, and board refreshment with five new trustees added since 2021. It references 2025 business performance and shareholder returns outperforming indices as detailed in the Form 10-K filed February 18, 2026, with no declines noted in the provided content.

• ·2026 Annual Meeting: Tuesday, June 16, 2026, at 11:00 a.m. Pacific Time, online at www.virtualshareholdermeeting.com/PMT2026.
• ·Record Date: April 20, 2026.
• ·Mail Date: April 21, 2026.
• ·Preston DuFauchard elected Independent Lead Trustee on March 19, 2024, for a three-year term.
• ·Shareholder right to amend bylaws: majority vote by group of up to five shareholders holding at least 1% of common shares for one year.
• ·Trustee limits: CEO limited to two outside public boards; others to five.
• ·2025 Form 10-K filed February 18, 2026.

21-04-2026

Ondas Inc. has issued a proxy statement for its 2026 Annual Meeting on May 28, 2026, seeking stockholder approval for electing four directors, ratifying BDO USA, P.C. as independent auditors for FY 2026, advisory approval of executive compensation, amending the charter to increase authorized common shares from 800,000,000 to 1,200,000,000, and amending the 2021 Stock Incentive Plan to increase authorized shares for issuance. As of the record date April 9, 2026, 481,883,390 shares of common stock are issued and outstanding. The Board recommends voting FOR all proposals, with no financial performance metrics or period comparisons disclosed.

• ·Annual Meeting time: 10:00 a.m. Eastern Time on Thursday, May 28, 2026
• ·Annual Meeting location: law offices of Akerman LLP at 777 South Flagler Drive, Suite 1100 West Tower, West Palm Beach, Florida 33401
• ·Record Date: close of business on April 9, 2026
• ·Voting deadline for proxies: 11:59 p.m. Eastern Time on May 27, 2026

21-04-2026

Energy Recovery, Inc. (ERII) issued its 2026 Proxy Statement for the virtual annual stockholder meeting on June 4, 2026, at 10:00 a.m. PT, seeking approval for election of six directors (five independent), advisory vote on executive compensation, ratification of Deloitte & Touche LLP as independent auditor, and Amendment No. 1 to the 2020 Incentive Plan; the Board recommends FOR all items. The proxy highlights a diverse board with two women directors, one racially/ethnically diverse director, and one of diverse national origin, alongside governance practices like stock ownership guidelines and no hedging/pledging. No specific financial performance metrics or period-over-period changes are detailed in the provided content.

• ·Record date: April 6, 2026
• ·Proxy materials mailed on or about April 20, 2026
• ·Virtual meeting access: www.virtualshareholdermeeting.com/ERII2026
• ·Board includes directors since 1995 (Arve Hanstveit); average tenure not specified but mix of long- and short-term
• ·Prohibitions on hedging and pledging shares; stock ownership guidelines in place

21-04-2026

AIRO Group Holdings, Inc. filed a DEF 14A proxy statement dated April 21, 2026, seeking stockholder approval for the election of three Class I directors (Gregory Winfree, Brian Nelson, and Sherrie McCandless) to serve until the 2029 Annual Meeting; the Board consists of nine members divided into three staggered classes with no reported vacancies or controversies. The filing outlines stockholder proposal deadlines for the 2027 Annual Meeting, including December 22, 2026 for Rule 14a-8 submissions and February 4 to March 6, 2027 for Bylaw notices. Detailed biographies highlight nominees' and continuing directors' extensive aerospace, manufacturing, government, and investment experience.

• ·Stockholder proposals under Rule 14a-8 for 2027 Annual Meeting due no later than December 22, 2026.
• ·Bylaw notices for 2027 proposals/nominations due between February 4, 2027 and March 6, 2027.
• ·Board vacancies filled by majority vote of directors then in office.
• ·No director or executive officer relationships by blood, marriage, or adoption; no selection arrangements.

21-04-2026

Standard Motor Products, Inc. (SMP) issued its definitive proxy statement (DEF 14A) on April 21, 2026, for the virtual Annual Meeting of Shareholders on May 21, 2026, at 2:00 p.m. EDT, with a record date of April 10, 2026, and 22,263,279 shares of common stock outstanding. Shareholders will vote to elect eight directors, ratify KPMG LLP as independent auditors for the fiscal year ending December 31, 2026, and approve an advisory resolution on named executive officer compensation. The filing accompanies the 2025 Annual Report and Form 10-K, and includes detailed executive compensation disclosures via XBRL tags for PEO and non-PEO NEOs across 2021-2025.

• ·Quorum requires majority of outstanding shares present in person or by proxy.
• ·Meeting held online at www.virtualshareholdermeeting.com/SMP2026.
• ·Proxy materials available at smpcorp.com under “For Investors—Financial Presentations & Documents.”

21-04-2026

Arcus Biosciences, Inc. filed a DEF 14A proxy statement dated April 21, 2026, for its virtual Annual Meeting of Stockholders on June 11, 2026, at 8:30 a.m. PT, with 125,628,682 shares of common stock outstanding as of the April 16, 2026 record date. Stockholders will vote on electing four Class II director nominees to serve until the 2029 annual meeting, ratifying Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026, and approving named executive officer compensation on an advisory basis. No financial performance metrics or period-over-period changes are disclosed in the provided filing content.

• ·Annual Meeting conducted entirely virtually via live webcast at www.virtualshareholdermeeting.com/RCUS2026 using 16-digit control number.
• ·Stockholder list available for examination 10 days prior to meeting at corporate headquarters (3928 Point Eden Way, Hayward, CA 94545) or during the meeting online.
• ·Proxy materials and Annual Report (Form 10-K for year ended December 31, 2025) available at www.proxyvote.com.

21-04-2026

Ormat Technologies, Inc.'s 2026 Proxy Statement for the June 2, 2026 virtual annual meeting seeks shareholder approval for electing eight directors, an advisory vote on named executive officer compensation, and ratification of Kesselman & Kesselman (PwC affiliate) as independent auditors. The shareholder letter from Chairman Isaac Angel and CEO Doron Blachar highlights 2025 operational successes including commercial operation of the 35MW Ijen Geothermal Facility in Indonesia, Arrowleaf 35MW/140MWh energy storage paired with 42MW solar, acquisition of Blue Mountain Geothermal Power Plant, and signing over 200MW in PPAs, with no declines or flat metrics noted. The company also added leadership team members Aron Willis and Daniel Moelk while advancing geothermal tech via partnerships with SLB and Sage Geosystems.

• ·Annual meeting: June 2, 2026 at 9:00 a.m. EDT, virtual at https://edge.media-server.com/mmc/p/p3grfokd
• ·Record date: April 8, 2026
• ·10-year PPA with Calpine Energy Solutions
• ·Tolling agreements for two energy storage facilities in Israel
• ·First energy storage projects outside the United States

21-04-2026

GoPro, Inc. filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 2, 2026, at 11:30 a.m. PT, seeking approval to elect seven incumbent directors, ratify PricewaterhouseCoopers LLP as independent auditor for the year ending December 31, 2026, approve executive compensation on an advisory basis, amend the 2024 Equity Incentive Plan to add 13,000,000 shares, and authorize the maximum issuance of Class A Common Stock upon conversion of Convertible Debentures per Nasdaq rules. The record date is April 7, 2026. No financial performance metrics or period-over-period comparisons are detailed in the provided filing content.

• ·Record date: April 7, 2026
• ·Virtual meeting access: www.virtualshareholdermeeting.com/GPRO2026
• ·Proxy materials available at www.proxyvote.com

21-04-2026

Argan, Inc.'s DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held on June 10, 2026, proposes the election of nine directors, a non-binding advisory 'say-on-pay' vote on executive compensation, and ratification of Grant Thornton LLP as independent registered public accountants for the fiscal year ending January 31, 2027. The company showcases robust financial metrics including $945M revenues, $9.74 diluted EPS, $163M EBITDA, $895M cash and investments, $421M net liquidity, and $2.93B backlog (80% power, 18% industrial, 2% teledata). No declines or flat performance were highlighted in the provided content.

• ·Annual Meeting date and time: June 10, 2026, at 11:00 a.m. local time
• ·Annual Meeting location: 4075 Wilson Boulevard, 2nd Floor Conference Center, Arlington, VA 22203
• ·Record date for stockholders: April 16, 2026
• ·Proxy materials available on or about April 30, 2026

21-04-2026

Cherry Hill Mortgage Investment Corp's DEF 14A proxy statement details 2025 quarterly performance with GAAP BVPS economic returns showing declines in Q1 (-2.4%) and Q2 (-2.5%) but improvements in Q3 (3.6%) and Q4 (5.4%), amid BVPS fluctuating from $3.58 to $3.44 and common dividends cut from $0.15 to $0.10 per share. Total stockholders’ equity grew modestly from $229,632 thousand to $238,532 thousand, while common stockholders’ equity rose from $116,933 thousand to $126,398 thousand. Executive compensation included base salaries of $1,235,000 for Mr. Lown, $550,000 for Mr. Evans, and prorated $213,699 for Ms. Healey, plus recruitment bonuses of $275,000 and $250,000 respectively, with no equity awards granted in 2025.

• ·No equity awards granted to NEOs in 2025; first post-2025 award was 24,414 RSUs to Ms. Healey vesting 2/10/27.
• ·Clawback policy adopted in 2023 compliant with Rule 10D-1 and NYSE standards.
• ·Aggregate liquidation preference of Series A and B Preferred Stock: $109,643 thousand each quarter.
• ·Filing date: April 21, 2026.

21-04-2026

Oklo Inc. (OKLO) has filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 3, 2026, at 12:00 p.m. ET, with a record date of April 6, 2026. Stockholders will vote on electing Caroline DeWitte, Richard W. Kinzley, and Dr. Mark Peters as Class II directors until the 2029 annual meeting and ratifying Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026. As of the record date, 173,919,838 shares of common stock were outstanding.

• ·Annual Meeting accessible via www.virtualshareholdermeeting.com/OKLO2026 using 16-digit control number.
• ·Business combination with AltC Acquisition Corp. completed on May 9, 2024.
• ·2025 Annual Report covers year ended December 31, 2025.

21-04-2026

NeuroPace's DEF 14A proxy statement proposes ratification of PricewaterhouseCoopers LLP (PwC) as independent auditors for the year ending December 31, 2026, after auditing since 1999; total fees declined approximately 6% YoY to $1,067,000 in 2025 from $1,134,500 in 2024, with audit fees dropping from $1,132,500 to $1,065,000 while all other fees remained flat at $2,000. As of April 9, 2026, 33,950,449 shares of common stock were outstanding, with major 5%+ holders including Accelmed Partners II LP (13.1%), Soleus (8.7%), and Polar Capital Partners (8.5%), and directors/executives as a group beneficially owning 19.2%. The filing details corporate governance policies, prohibits hedging, and lists executive officers including new CFO Patrick Williams since June 2025.

• ·PwC has audited NeuroPace financial statements since 1999.
• ·Audit Committee pre-approves all services; determined PwC independence compatible.
• ·Mr. Huennekens no longer serves on Audit Committee effective March 30, 2026.
• ·Proxy statement filed April 21, 2026; ownership data as of April 9, 2026.

21-04-2026

Evommune, Inc. (EVMN) has filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders, to be held virtually on June 2, 2026 at 11:30 a.m. ET. Shareholders of record as of April 6, 2026 will vote on electing two Class I directors, Luis Peña and Eugene A. Bauer, M.D. (terms until 2029), and ratifying BDO USA, P.C. as independent auditor for the fiscal year ending December 31, 2026. The filing provides voting instructions and details access via www.virtualshareholdermeeting.com/EVMN2026.

• ·Record date: April 6, 2026
• ·Filing date: April 21, 2026
• ·Meeting location: Virtual at www.virtualshareholdermeeting.com/EVMN2026 (check-in from 11:15 a.m. ET)
• ·Company address: 1891 Page Mill Road, Palo Alto, California 94304

21-04-2026

Mercer International's DEF 14A proxy statement for the June 1, 2026 annual meeting seeks shareholder approval for election of nine directors (8 independent), advisory vote on executive compensation, and ratification of PricewaterhouseCoopers LLP as auditors for fiscal 2026. Fiscal 2025 results showed sharp deterioration with net loss expanding to $(497.9)M from $(85.1)M in 2024, operating loss of $(397.7)M versus $15.0M income, and Operating EBITDA swinging to $(22.0)M from $243.7M amid $215.7M long-lived asset impairments and challenging hardwood pulp markets. However, the company realized $30.0M in cost savings toward its 'One Goal One Hundred' program's $100.0M target by end-2026, invested $88.6M in capital projects, and progressed mass timber order book and carbon capture pilot.

• ·Annual Meeting: June 1, 2026 at 10:00 a.m. Vancouver time, Suite 1120, 700 West Pender Street, Vancouver, BC; virtual option at www.meetnow.global/MP7FK25
• ·Record Date: March 26, 2026
• ·Board held 16 full meetings and 11 independent director-only meetings in 2025
• ·Implemented capital projects including wood room at Celgar mill, log yard upgrades at Torgau and Friesau, digester evaporator and turbine at Rosenthal, lime kiln at Stendal
• ·Achieved record lumber production at Torgau facility in 2025
• ·50% scope 1 GHG emissions reduction target
• ·Annual director elections by majority vote; director stock ownership guidelines in place

21-04-2026

26North BDC, Inc. filed a definitive proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 4, 2026 at 10:00 a.m. ET, seeking to elect a Class III director for a three-year term expiring at the 2029 annual meeting and to ratify Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Stockholders of record as of the close of business on March 30, 2026 are entitled to vote, with the Board unanimously recommending votes 'FOR' both proposals. Proxy materials and the Annual Report on Form 10-K for the fiscal year ended December 31, 2025 are available online via www.proxyvote.com.

• ·Company address: 600 Madison Avenue, 26th Floor, New York, NY 10022.
• ·Virtual meeting access: www.virtualshareholdermeeting.com/26NP2026 using control number from Broadridge.
• ·Contact for questions: (212) 224-0626.

21-04-2026

Cricut, Inc. (CRCT) filed its DEF 14A proxy statement dated April 21, 2026, for the virtual annual stockholder meeting on June 3, 2026, at 10:00 a.m. MT. Stockholders of record as of April 6, 2026, will vote on electing seven directors, an advisory approval of named executive officer compensation, and ratification of BDO USA, P.C. as independent auditor for fiscal year ending December 31, 2026. The Board recommends voting FOR all proposals.

• ·Class A shares entitled to 1 vote each; Class B shares entitled to 5 votes each.
• ·Meeting accessible virtually at www.virtualshareholdermeeting.com/CRCT2026.
• ·Proxy materials available at www.proxyvote.com as of April 21, 2026.

21-04-2026

BioAge Labs, Inc. will hold its 2026 Annual Meeting of Stockholders virtually on June 10, 2026 at 12:00 p.m. ET to elect three Class II directors for a three-year term and ratify the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date is April 16, 2026, with 44,397,817 shares of common stock outstanding, and the Board unanimously recommends voting FOR both proposals. Proxy materials are available online at www.proxydocs.com/BIOA, with voting options via internet, phone, or mail.

• ·Annual Meeting quorum requires majority of voting power present or by proxy.
• ·Directors elected by plurality vote; ratification requires majority of votes cast FOR.
• ·Company address: 5885 Hollis Street, Suite 370, Emeryville, California 94608.
• ·Investor relations email: ir@bioagelabs.com.

21-04-2026

Abacus Global Management, Inc. filed its DEF 14A Proxy Statement on April 21, 2026, for the virtual Annual Meeting of Stockholders on June 3, 2026 (record date April 20, 2026), seeking approval for electing Class III directors Jay Jackson and Thomas W. Corbett, Jr. (terms until 2029), ratifying KPMG LLP as auditors for FY 2026, adopting the 2026 Long-Term Equity Incentive Plan, and advisory votes on executive compensation and say-on-pay frequency. No financial performance metrics or period-over-period comparisons are detailed in the provided filing excerpt. The statement includes standard forward-looking disclosures and references the 2025 Annual Report filed March 13, 2026.

• ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/ABX2026 at 4:00 p.m. Eastern Time.
• ·Company address: 2101 Park Center Drive, Suite 200, Orlando, Florida 32835.
• ·Proxy materials mailed on or about April 23, 2026, including 2025 Form 10-K.

21-04-2026

Ligand Pharmaceuticals Incorporated's DEF 14A proxy statement, filed April 21, 2026, outlines the virtual annual stockholder meeting on June 5, 2026, to elect eight directors (Jason M. Aryeh, Todd C. Davis, Nancy R. Gray Ph.D., Jason Haas, John W. Kozarich Ph.D., John L. LaMattina Ph.D., Stephen L. Sabba M.D., Martine Zimmermann Pharm.D.), ratify Ernst & Young LLP as auditors for FY 2026, approve NEO compensation on an advisory basis, and approve amendment/restatement of the 2002 Stock Incentive Plan. The proxy highlights exceptional 2025 financial performance, including royalty revenue growth of 48% YoY and adjusted EPS increase of 42% YoY, exceeding original guidance by more than 30%, driven by ramps in Filspari (Travere), launches of Ohtuvayre and Capvaxive (Merck), Zelsuvmi (Pelthos), and Qarziba (Recordati); no declines or flat metrics were reported. A key strategic achievement was the merger of Pelthos Therapeutics with Channel Therapeutics, generating equity and royalty value.

• ·Record Date: April 16, 2026
• ·Virtual meeting link: https://meetnow.global/MQ42GX6
• ·Fiscal year reference: ended December 31, 2025

21-04-2026

Arteris, Inc. (AIP) filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders on June 2, 2026 (virtual at 8:30 a.m. PT), soliciting votes for Proposal 1: election of three Class II directors (plurality vote) and Proposal 2: ratification of Deloitte & Touche LLP as independent auditors for the year ending December 31, 2026 (majority of votes cast). As of the Record Date (April 9, 2026), 46,092,618 shares of common stock were outstanding. No financial performance metrics or period comparisons are discussed.

• ·Annual Meeting registration deadline: June 1, 2026 at 5:00 p.m. ET (2:00 p.m. PT) at www.proxydocs.com/AIP
• ·Proxy materials first available on or about April 21, 2026
• ·Proposal 1 (director election) is non-routine (potential broker non-votes); Proposal 2 (auditor ratification) is routine (no expected broker non-votes)
• ·Form 10-K for year ended December 31, 2025 available via Notice of Internet Availability or at https://ir.arteris.com/

21-04-2026

Booking Holdings Inc. filed its 2026 Definitive Proxy Statement (DEF 14A) on April 21, 2026, for the Annual Meeting of Stockholders on June 2, 2026. The proxy seeks stockholder approval for the election of directors, an advisory vote on 2025 executive compensation (including pay versus performance data for 2021-2025 and CEO pay ratio), ratification of the independent auditor, a board proposal to amend the certificate of incorporation for officer exculpation, and two stockholder proposals on corporate political spending and business operations in illegal settlements. It highlights corporate governance practices, board oversight, sustainability efforts, and executive compensation philosophy amid optimism for growth driven by generative AI.

• ·Annual Meeting date: June 2, 2026
• ·Fiscal year end: December 31
• ·Operates in over 220 countries and territories and 40+ languages
• ·Proposals include advisory vote on 2025 executive compensation, ratification of independent registered public accounting firm, amendment to Restated Certificate of Incorporation for officer exculpation, stockholder proposal on avoiding brand damage due to corporate political spending, and stockholder proposal regarding business operations in illegal settlements

21-04-2026

Heritage Global Inc. (HGBL) has issued a proxy statement for its 2026 Annual Meeting of Shareholders, to be held virtually on June 3, 2026 at 9:00 a.m. PT, seeking approval to elect Michael Hexner and William Burnham as Class II directors and to ratify UHY LLP as independent auditor for the fiscal year ending December 31, 2026. The record date is April 6, 2026, with 34,734,754 common shares (one vote each) and 563 Series N Preferred shares (40 votes each, totaling 22,520 votes) outstanding, for a total of 34,757,274 votes eligible.

• ·Annual Meeting is virtual only at www.virtualshareholdermeeting.com/HGBL2026; no physical location.
• ·Proxy materials and 2025 Annual Report (Form 10-K for year ended December 31, 2025) available at www.proxyvote.com.
• ·Company address: 6130 Nancy Ridge Drive, San Diego, California 92121.

21-04-2026

Trevi Therapeutics, Inc. filed a DEF 14A proxy statement dated April 21, 2026, for its virtual Annual Meeting on June 3, 2026, proposing the election of one Class I director, ratification of Ernst & Young LLP as independent auditors for fiscal year ending December 31, 2026, advisory approval of named executive officer compensation, approval of the Amended and Restated 2019 Stock Incentive Plan, and an amendment to increase authorized common shares from 200,000,000 to 400,000,000. As of the record date April 6, 2026, 128,586,792 shares of common stock were issued and outstanding. No other financial metrics or period-over-period comparisons are detailed in the filing.

• ·Annual Meeting: 11:00 a.m. Eastern Time on June 3, 2026, virtual via www.virtualshareholdermeeting.com/TRVI2026
• ·Proxy submission deadlines: telephone/Internet by 11:59 p.m. ET June 2, 2026; mail by June 2, 2026
• ·Notice mailing: on or about April 23, 2026
• ·Company address: 195 Church Street, 16th Floor, New Haven, CT 06510

21-04-2026

TPG Inc.'s 2026 DEF 14A proxy statement seeks stockholder approval for the election of 14 directors at the Annual Meeting, including the 13 current directors (9 management and 4 independent) and new appointee Mr. McRaven effective May 1, 2026. As a controlled company, TPG is not required to have a majority independent board but has a plan for founder succession and transition to majority independent oversight. The filing references the company's Reorganization and IPO completed in January 2022, with no material financial performance changes disclosed.

• ·Annual Report on Form 10-K for year ended December 31, 2025 filed with SEC on February 17, 2026.
• ·Proxy materials first released to stockholders on or about April 21, 2026.
• ·Directors serve one-year terms, elected by plurality vote.

21-04-2026

Ares Management Corporation filed its DEF 14A Proxy Statement on April 21, 2026, for the 2026 Annual Meeting of Stockholders to be held virtually on June 8, 2026, at 1:00 p.m. Eastern Time. The agenda includes the election of directors for one-year terms expiring in 2027 (Proposal 1) and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the 2026 fiscal year (Proposal 2). The filing contains XBRL tags referencing compensation adjustments for the Principal Executive Officer (PEO) and Non-PEO Named Executive Officers (NEOs) across 2021-2025, but no specific monetary figures are detailed in the provided content.

• ·Annual Meeting conducted in virtual-only format at www.virtualshareholdermeeting.com/ARES2026
• ·Stockholders can submit questions in advance or live during the meeting, subject to rules of conduct and time constraints

21-04-2026

Power Integrations' DEF 14A proxy statement for the June 3, 2026 annual meeting highlights 2025 financial performance with revenue up 6% YoY, non-GAAP EPS up 8% YoY, operating cash flow at $112 million (up $30 million YoY), and $145 million returned to stockholders via dividends and repurchases; the board approved a 2.4% dividend increase for Q1 2026. Proposals include electing seven directors, advisory approval of executive compensation, ratification of Deloitte & Touche LLP as auditors for FY 2026, amendment to increase shares under the 2016 Incentive Award Plan, and a stockholder proposal to separate Chairman and CEO roles (board recommends against). The company emphasizes strong balance sheet, operational discipline, and stockholder engagement under new CEO Jennifer A. Lloyd, who assumed the role in July 2025.

• ·Annual Meeting: June 3, 2026 at 8:00 a.m. PT via live webcast at https://meetnow.global/MJPQAXN
• ·Record date: April 13, 2026
• ·Fiscal year for auditor ratification: ending December 31, 2026
• ·CEO transition: Jennifer A. Lloyd stepped into CEO role in July 2025

21-04-2026

Amerant Bancorp Inc.'s DEF 14A proxy statement details corporate governance practices, including Compensation Committee activities such as delegating authority to grant up to 150,000 shares of Class A Voting Common Stock for talent retention, first to Gerald P. Plush in January 2025 and then to Carlos Iafigliola in November 2025 with 54,988 shares remaining. In November 2025, Gerald P. Plush stepped down as Chairman, President, CEO, and Board member; Carlos Iafigliola was appointed Interim CEO, and Odilon Almeida became non-executive Chair, separating the Chair and CEO roles previously combined. The filing also covers board committees, independence, a related party transaction involving $289,000 compensation to Gustavo Marturet M.'s brother-in-law, and the use of a third-party consultant for 2025 board evaluations.

• ·Compensation Committee delegated equity grant authority to Gerald P. Plush in January 2025 and transferred it to Carlos Iafigliola in November 2025 on same terms, excluding grants to NEOs, Section 16 Officers, or Directors.
• ·All Governance, Risk, and Compensation Committee members determined independent under NYSE/SEC rules, except noted related party for Marturet.
• ·Board used independent third-party consultant for 2025 evaluations, including director interviews and peer feedback.

21-04-2026

Crescent Biopharma, Inc. (CBIO) filed a DEF 14A proxy statement for its virtual Annual General Meeting on June 2, 2026, seeking shareholder approval to elect two Class II directors—Jonathan Violin, Ph.D. (by Series A preferred shareholders) and Susan Moran, M.D., MSCE (by ordinary and Series A preferred shareholders)—to serve until 2029, ratify PricewaterhouseCoopers LLP as auditors for FY ending December 31, 2026, approve named executive officer compensation on an advisory basis, and set the frequency of future say-on-pay votes to one year. The record date is April 7, 2026, with the board recommending votes 'FOR' all proposals except frequency ('ONE-YEAR'). Background notes a 2025 merger with Pre-Merger Crescent and redomestication to Cayman Islands.

• ·Record date: April 7, 2026
• ·Meeting location: Virtual via live audio-only webcast at www.virtualshareholdermeeting.com/CBIO2026, check-in at 8:45 a.m. ET
• ·Series A preferred shares convertible into 1,000 ordinary shares (subject to adjustment)
• ·Merger closing: June 13, 2025; Redomestication to Cayman Islands: June 16, 2025
• ·Ordinary shares and Series A preferred shares have par value $0.001 each

21-04-2026

OnKure Therapeutics, Inc., formed via merger with Legacy OnKure on October 4, 2024 (including 1:10 reverse stock split), will hold its 2026 annual stockholder meeting virtually on June 3, 2026, to elect three Class II directors (term until 2029), ratify KPMG LLP as independent auditors for fiscal year ending December 31, 2026, and approve amendment/restatement of the 2024 Equity Incentive Plan increasing reserved Class A Common Stock shares by approximately 8% of outstanding shares while removing the 2,407,100-share annual evergreen limit. As of the April 16, 2026 record date, 40,395,480 shares of Class A Common Stock were outstanding. No other matters are anticipated.

• ·Annual meeting is completely virtual via www.virtualshareholdermeeting.com/OKUR2026; in-person attendance not permitted.
• ·Proxy materials available starting April 21, 2026 at www.proxyvote.com.
• ·Merger closed October 4, 2024; Legacy OnKure became wholly owned subsidiary then merged into OnKure Therapeutics, Inc.

21-04-2026

Virgin Galactic Holdings, Inc. (SPCE) filed its DEF 14A Proxy Statement on April 21, 2026, for the 2026 annual stockholder meeting on June 11, 2026, at 9:00 a.m. Pacific Time (virtual), with record date April 15, 2026. Key proposals include electing directors, ratifying Ernst & Young LLP as independent auditors for 2026, advisory approval of named executive officer compensation, approval of the Fourth Amended and Restated 2019 Incentive Award Plan, and advisory vote on say-on-pay frequency. No financial performance metrics or period-over-period changes are detailed in the filing.

• ·Meeting registration required by 8:59 p.m. PT on June 10, 2026 at https://web.viewproxy.com/SPCE/2026.
• ·Stockholder list available for examination 10 days prior to meeting via email to CorporateSecretary@virgingalactic.com.
• ·Proxy materials available at https://web.viewproxy.com/SPCE/2026.

21-04-2026

Marqeta, Inc. issued its definitive proxy statement (DEF 14A) on April 21, 2026, for the virtual Annual Meeting of Stockholders on June 10, 2026 (record date April 15, 2026), seeking approval to elect four Class II directors to serve until 2029, ratify KPMG LLP as independent auditors for the fiscal year ending December 31, 2026, approve a 1-for-4 reverse stock split with related authorized share reductions, adopt an officer exculpation amendment under Delaware law, and conduct an advisory vote on named executive officer compensation. The filing includes governance details, director nominees, executive compensation discussion (with XBRL tags referencing PEOs Simon Khalaf, Michael Milotich, and prior PEO Jason Gardner for years 2021-2025), and non-employee director compensation information. No financial performance metrics, period-over-period changes, or declines are detailed in the provided content.

• ·Annual Meeting Date/Time: June 10, 2026 at 11:30 AM ET (virtual at www.virtualshareholdermeeting.com/MQ2026)
• ·Record Date: April 15, 2026
• ·Reverse stock split ratio: 1-for-4
• ·Fiscal year reference: Annual Report for year ended December 31, 2025
• ·Proxy materials available at www.proxyvote.com

21-04-2026

Rithm Property Trust Inc. (RPT) filed a DEF 14A proxy statement dated April 21, 2026, for its 2026 Annual Meeting of Stockholders on June 2, 2026, soliciting votes on four proposals: election of directors, ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026, non-binding advisory approval of executive compensation, and approval of the 2026 Omnibus Incentive Plan. As of the record date April 13, 2026, 7,661,770 shares of common stock were outstanding, with quorum requiring a majority of votes entitled to be cast. The filing provides standard governance details including voting procedures, with no period-over-period financial comparisons or performance metrics disclosed in the excerpt.

• ·Proposal 1 (Election of Directors): Plurality vote; four nominees receiving highest FOR votes elected; abstentions and broker non-votes not counted as votes cast.
• ·Proposal 2 (Auditor Ratification): Routine matter; brokers may vote without instructions; majority of votes cast required.
• ·Proposal 3 (Say-on-Pay): Non-binding advisory; majority of votes cast required.
• ·Proposal 4 (Omnibus Incentive Plan): Majority of votes cast required; non-routine.
• ·Proxy materials available at www.proxyvote.com; voting deadline 11:59 p.m. ET day before meeting.

21-04-2026

BillionToOne, Inc. (BLLN) has issued a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 10, 2026, at 9:00 a.m. PDT, with stockholders of record as of April 17, 2026 entitled to vote on electing two Class I directors (to serve until 2029) and ratifying PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026. As of the record date, there were 45,994,764 shares of common stock outstanding, consisting of 41,442,114 shares of Class A common stock (1 vote per share) and 4,552,650 shares of Class B common stock (15 votes per share). Proxy materials, including the Form 10-K for the year ended December 31, 2025, are available at www.proxyvote.com.

• ·Class A common stock entitled to 1 vote per share; Class B common stock entitled to 15 votes per share.
• ·Annual Meeting quorum requires majority of voting power of shares entitled to vote.
• ·Proxy materials made available on or about April 21, 2026.

21-04-2026

Grocery Outlet Holding Corp. (GO) filed its DEF 14A Proxy Statement on April 21, 2026, for the 2026 Annual Meeting of Stockholders, including proposals for election of directors, ratification of independent auditors, advisory vote to approve executive compensation, and advisory vote on the frequency of say-on-pay votes. The filing features compensation discussion and analysis, summary compensation tables, pay versus performance disclosures over fiscal years 2021-2025 for Principal Executive Officers (PEOs) including Eric J. Lindberg Jr., Robert J. Sheedy Jr., and Jason Potter, and details on outstanding equity awards and potential payments upon termination. No specific financial performance metrics or period-over-period changes are detailed in the provided content.

• ·Fiscal periods covered: 2021 (Jan 3, 2021 - Jan 2, 2022), 2022 (Jan 2, 2022 - Dec 31, 2022), 2023 (Jan 1, 2023 - Dec 30, 2023), 2024 (Dec 31, 2023 - Dec 28, 2024), 2025 (Dec 29, 2024 - Jan 3, 2026)
• ·Proxy materials available at www.proxyvote.com
• ·Includes CEO Pay Ratio and Equity Compensation Plan Information

21-04-2026

Weatherford International plc's DEF 14A proxy statement, filed April 21, 2026, seeks shareholder approval at the June 11, 2026 Court Meeting and AGM for a scheme of arrangement to redomesticate from Ireland to Texas, US, as Weatherford International Corp., alongside standard items like director elections, auditor ratification, advisory vote on 2025 executive compensation, and equity incentive plan approval. The document includes compensation discussion and analysis for 2021-2025, pay-for-performance data, and comparisons of shareholder rights before and after redomestication. No specific financial performance metrics or period-over-period changes are detailed in the provided content.

• ·Shareholder meetings scheduled for June 11, 2026: Court Meeting at 8:00 a.m. CT / 2:00 p.m. Irish Time; AGM at 8:10 a.m. CT / 2:10 p.m. Irish Time.
• ·Compensation data covers fiscal years 2021 through 2025 for Principal Executive Officer (PEO) and Non-PEO Named Executive Officers (NEOs).
• ·Proxy materials mailed beginning April 21, 2026 to shareholders of record.

21-04-2026

BioMarin Pharmaceutical Inc.'s 2026 Proxy Statement outlines the Annual Meeting on June 2, 2026, to elect 10 directors, ratify KPMG as auditors, approve NEO compensation advisory vote, and amend the 2017 Equity Incentive Plan; it highlights 2025 record revenues of $3.2 billion (up 13% YoY following 18% growth in 2024) and operating cash flow approaching $1 billion, with acquisitions of Inozyme Pharma and pending Amicus Therapeutics. However, the company announced voluntary withdrawal of ROCTAVIAN from the market in February 2026. Leadership transitions include Richard A. Meier retiring as Board Chair, succeeded by Ian Clark.

• ·Annual Meeting record date: April 7, 2026
• ·Proxy materials mailed on or about April 21, 2026
• ·Inozyme Pharma acquisition closed in July 2025
• ·Amicus Therapeutics acquisition pending
• ·ROCTAVIAN voluntarily withdrawn from market in February 2026

21-04-2026

Axalta Coating Systems Ltd.'s DEF 14A Proxy Statement, filed April 21, 2026, solicits votes for the June 3, 2026 Annual General Meeting on electing nine directors (all non-employee directors independent), appointing PricewaterhouseCoopers LLP as auditor, and a non-binding advisory vote approving named executive officer compensation, which features strong alignment with company performance under independent committee oversight. The statement references the pending merger with AkzoNobel, the 2024-2026 '2026 A Plan' strategy, and the 2024 Transformation Initiative, while cautioning on risks including execution challenges and external factors like tariffs. No declines or flat performance metrics are detailed in the provided content.

• ·Annual General Meeting: June 3, 2026 at 10:00 a.m. ET, Axalta Corporate Headquarters, Philadelphia, PA
• ·Record Date: April 9, 2026
• ·Executive compensation disclosures cover fair value changes in equity awards for PEO and Non-PEO NEOs across 2021-2025

21-04-2026

CVR Energy, Inc. issued its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders on June 4, 2026 (virtual), soliciting votes to elect ten director nominees for one-year terms, approve named executive officer compensation on an advisory basis, and ratify the independent auditor for fiscal 2026. The Company, focused on petroleum refining/marketing and holding a 37% interest in CVR Partners, LP for nitrogen fertilizer manufacturing, reports Icahn Enterprises L.P. affiliates owning approximately 71% of its common stock as of April 17, 2026. Mark A. Pytosh assumed the role of President and CEO on January 1, 2026, with no notable performance declines highlighted in the governance overview.

• ·Record Date: April 6, 2026
• ·Annual Meeting: Thursday, June 4, 2026 at 10:00 a.m. Central Daylight Time via live webcast at www.virtualshareholdermeeting.com/CVI2026
• ·Proxy materials and 2025 Annual Report available at www.proxyvote.com on or about April 21, 2026

21-04-2026

Arcutis Biotherapeutics, Inc. (ARQT) has filed a definitive proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 5, 2026, at 7:30 a.m. PDT, seeking approval for the election of three Class III directors to serve until the 2029 annual meeting, ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026, and non-binding advisory approval of named executive officer compensation. The record date is April 8, 2026, with 125,073,249 shares of common stock outstanding entitled to vote. The Board recommends voting 'FOR' all three proposals.

• ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/ARQT2026
• ·Proxy materials first available on or about April 21, 2026
• ·References Annual Report on Form 10-K for year ended December 31, 2025

21-04-2026

Denali Therapeutics Inc. filed its DEF 14A definitive proxy statement on April 21, 2026, for the 2026 Annual Meeting of Stockholders, to be held virtually on June 3, 2026 at 10:00 a.m. Pacific Time. Stockholders of record as of April 9, 2026, will vote on electing three Class III directors to serve until the 2029 annual meeting, ratifying Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026, and approving executive compensation on an advisory basis. No financial performance metrics or period-over-period comparisons are detailed in the provided filing content.

• ·Annual Meeting accessible via www.virtualshareholdermeeting.com/DNLI2026 using 16-digit control number.
• ·Proxy materials available at www.proxyvote.com and https://denalitherapeutics.com/investors.
• ·Company address: 161 Oyster Point Blvd., South San Francisco, California 94080.

21-04-2026

Aurinia Pharmaceuticals Inc. filed its DEF 14A definitive proxy statement on April 21, 2026, for the 2026 Annual General Meeting of Shareholders to be held virtually on June 3, 2026, at 12:00 p.m. ET. Shareholders of record as of April 14, 2026, will vote on electing five director nominees, ratifying PricewaterhouseCoopers LLP as independent auditors until the 2027 meeting, and an advisory 'say-on-pay' vote on executive compensation. Proxy materials, including the 2025 Form 10-K, are available electronically via www.proxyvote.com, www.sedarplus.ca, www.sec.gov, and the company's investor website.

• ·Record date: April 14, 2026
• ·Proxy deposit deadline: 11:59 p.m. ET on June 2, 2026 (or 48 hours before any adjournment)
• ·Virtual meeting link: https://meetings.lumiconnect.com/400-059-506-004 (password: aurinia2026)
• ·Proxy materials provided via notice-and-access; paper copies available upon request
• ·XBRL disclosures reference pay vs. performance data for PEO and Non-PEO NEOs from 2021-2025, including equity awards and fair value adjustments

21-04-2026

MoonLake Immunotherapeutics' DEF 14A proxy statement solicits votes for its 2026 Annual General Meeting on June 4, 2026, including election of a Class I director nominee to serve until the 2029 AGM, ratification of Baker Tilly US, LLP as independent auditor for the year ending December 31, 2026, advisory approval of named executive officer compensation, and amendment/restatement of the 2022 Equity Incentive Plan. The record date is April 9, 2026, with 72,852,170 Class A Ordinary Shares outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are provided in the filing excerpt.

• ·Annual Meeting location: offices of Gibson, Dunn & Crutcher LLP, 200 Park Avenue, New York, New York 10166
• ·Annual Meeting time: 8:00 a.m. Eastern Time
• ·Record date: April 9, 2026
• ·Filing date: April 21, 2026
• ·Auditor selection for year ending: December 31, 2026
• ·Director term: until 2029 Annual General Meeting of Shareholders

21-04-2026

Joby Aviation, Inc. has issued a proxy statement for its 2026 Annual Meeting on June 2, 2026, held virtually, seeking stockholder approval to elect three Class II directors (Paul Sciarra, Halimah DeLaine Prado, and Laura Wright) for three-year terms, ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2026, and approve named executive officer compensation in a non-binding advisory vote. The record date is April 7, 2026, with 983,169,282 shares of common stock outstanding entitled to vote. The board recommends voting FOR all proposals, with no other matters anticipated.

• ·Annual Meeting time: 9:00 a.m. Pacific Time, accessible at www.virtualshareholdermeeting.com/JOBY2026 using 16-digit control number.
• ·Notice of Internet Availability mailed on or about April 21, 2026.
• ·2021 business combination with Reinvent Technology Partners completed on August 10, 2021.

21-04-2026

LendingClub Corporation's 2026 Proxy Statement highlights strong 2025 financial performance, including loan originations growing 33% YoY to $9.6B from $7.2B, total assets expanding to $11.6B, and net income reaching $135.7M, alongside more than doubling EPS and achieving double-digit RO TCE. The annual meeting on June 2, 2026, seeks stockholder approval for electing three Class III directors (Kathryn Reimann, Scott Sanborn, Michael Zeisser), advisory vote on executive compensation, ratification of Deloitte & Touche LLP as auditor, phasing in board declassification, and removing supermajority voting requirements. Cumulative since 2006, the platform has served over 5 million members and originated more than $100B in loans.

• ·Hans Morris stepping down from Board after nearly 13 years, including 10 as Chairman.
• ·Acquired Mosaic intellectual property to enter home improvement financing in H1 2026.
• ·Stockholder outreach in 2024, 2025, and 2026 reached 46%, 33%, and 58% of outstanding shares respectively; conversations thus far in 2026 with holders of 26% of shares.
• ·2025 governance proposals received >99% support from voting stockholders but fell short of two-thirds of outstanding shares.
• ·Annual Meeting record date: April 9, 2026; meeting via webcast at www.virtualshareholdermeeting.com/LC2026.

21-04-2026

Red Violet, Inc. (RDVT) filed its DEF 14A definitive proxy statement on April 21, 2026, for the virtual-only 2026 Annual Meeting of Stockholders on June 3, 2026, at 11:00 a.m. ET. Stockholders are asked to vote on electing five directors for a one-year term, ratifying Grant Thornton LLP as independent auditor for the year ending December 31, 2026, and a non-binding advisory 'Say on Pay' vote on named executive officers' compensation. As of the record date April 9, 2026, 14,112,391 shares of common stock were outstanding.

• ·Record date: April 9, 2026.
• ·Meeting registration deadline: June 2, 2026, at 11:59 p.m. ET at www.proxydocs.com/RDVT.
• ·Voting on matters requires majority quorum; Election of Directors by plurality.
• ·Proxy materials and 10-K for year ended December 31, 2025 available at www.redviolet.com.